Medication info
Daprodia Tablets 10 mg (Dapagliflozin Propanediol Hydrate)

Daprodia Tablets 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Kwangdong Pharmaceutical Co., Ltd.
Appearance
Yellow, convex, diamond-shaped film-coated tablet
Packaging
PTP - 28 tablets per box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets per bottle
Approval status
Active

MFDS item code 202202180 · Approved 2022.05.23 · Insurance code 641807180

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of antidiabetic drug treatment, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Kwangdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorders
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used alone or in combination with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It may also be given to patients with insufficient blood sugar control and existing cardiovascular disease or risk factors, however, careful use must be followed according to relevant clinical trial information. This medication assists in diabetes management by improving blood sugar control.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of antidiabetic drug treatment, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with allergies to the main ingredient or excipients, or in patients with type 1 diabetes or diabetic ketoacidosis. Moreover, patients with lactose intolerance or specific genetic issues and patients undergoing dialysis should not take this medication. Caution is required for patients with reduced fluid volume or renal dysfunction, and blood pressure and kidney function should be closely monitored before and after administration. This medication may have reduced blood sugar control efficacy in patients with severely impaired kidney function. There is a risk of genital and urinary tract infections during treatment, and immediate treatment is necessary if symptoms develop. Due to the risk of hypoglycemia, dosage adjustments may be needed when taken alongside insulin or sulfonylureas. Watch for dehydration or hypotension symptoms due to reduced fluid volume, and temporarily discontinue use if symptoms are severe. There is a risk of diabetic ketoacidosis, so immediate hospital visit is required if symptoms such as vomiting, abdominal pain, or shortness of breath occur. Serious infection symptoms like necrotizing fasciitis are rarely reported, so consult a doctor if there is pain or redness around the genital area. Elderly patients or those with renal dysfunction should use this medication with extra caution, and regular kidney function tests are recommended. Pregnant or breastfeeding women should not take this medication and should discontinue use upon confirmation of pregnancy. There is no specific antidote for overdose; appropriate treatment should be administered according to symptoms. This medication does not significantly affect driving or machinery operation, but caution is needed due to potential hypoglycemia symptoms. Safety and efficacy in children under 18 years have not yet been established, and its use is not recommended. This medication must be stored in its original container and kept out of reach of children.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased creatinine clearance at the start of treatment, dyslipidemia, increased serum creatinine at the start of treatment, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, nasopharyngitis, upper respiratory infection, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament strain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus, urinary retention, abnormal urination, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, hypogeusia, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormal eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, increased appetite, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, loss of consciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, diverticulitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, chest pain, fatigue, pain, edema, foreign body sensation, breast pain, menstrual irregularities, vaginal discharge, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament strain, dry eye, eye pain, retinal disorders, vision loss, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, high intraocular pressure, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, obstructive sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, angina pectoris, atrial fibrillation, diastolic dysfunction, anxiety disorder, nocturia, auditory hallucinations, sleep disorders, cholangitis, hepatic cysts, dizziness, anal genital warts, adenoma of the stomach, neuroma, male hypogonadism, thyroid cysts, thyroid nodules, food allergies, polycythemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best stored at a cool room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, convex, diamond-shaped film-coated tablet

Package unit

PTP - 28 tablets per box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.